Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
13.78x2.16x-0.87x2.73x7.69x8.39x-.--% 1.35TCr
49.61x5.42x-2.45x8.53x37.82x39.22x-.--% 3.47TCr
18.99x3.37x0.7x4.74x13.07x15.33x1.52% 3.14TCr
-23.89x1.29x-0.52x5.93x-9.68x-8.99x-.--% 2.77TCr
-66.37x - -2.28x - -67.15x-65.43x-.--% 2.1TCr
-19.64x58.12x4.48x43.76x-21.52x-21.26x-.--% 1.99TCr
1188.59x15.01x-10.23x29.12x340.45x1589.07x-.--% 1.44TCr
25.79x2.15x1.09x4.53x13.16x16.81x-.--% 1.41TCr
19.46x4.38x0.63x4.69x13.44x14.07x-.--% 1.22TCr
-118.89x25.88x-0.9x36.95x-200.74x-117.87x-.--% 1.03TCr
353.05x - -3.1x21.02x - 250.09x - 891.67Cr
-27.01x14.63x0.65x10.49x-18.64x-20.98x-.--% 765.95Cr
-45.5x7.38x5.06x6.6x-60.3x-53.88x-.--% 732.55Cr
24.7x6.35x1x - - - - 614.21Cr
62.62x2.14x-2.46x3.68x16.72x30.46x0.29% 613.67Cr
-17.26x6.92x-0.66x - -18.42x-15.94x-.--% 613.61Cr
30.22x5.49x0.31x10.06x31.51x34.09x-.--% 600.74Cr
-40.72x20.02x0.94x16.31x-73.15x-54.51x-.--% 516.11Cr
-7.59x - -0.28x - - - -.--% 471.77Cr
Average 74.73x 11.29x -0.47x 13.94x 0.26x 96.39x 0.11% 1.36TCr
Weighted average by Cap. 75.84x 11.12x -0.68x 13.31x 8.90x 96.02x 0.2%
Bio Therapeutic Drugs